Skip to main content

Table 1 Demographic data and clinical characteristics of patients with adult-onset Still’s disease (AOSD), patients with systemic lupus erythematosus (SLE), and healthy controls (HC)#

From: The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still’s disease

 

AOSD (n = 52)

SLE (n = 36)

HC (n = 16)

Age at study entry (years)

37.1 ± 13.4

38.0 ± 12.1

32.5 ± 6.1

Proportion of females

37 (71.2%)

30 (83.3%)

10 (62.5%)

Serum creatinine (mg/dL)

0.84 ± 0.14

0.96 ± 0.92

0.89 ± 0.17

Body mass index (kg/m2)

22.6 ± 2.7

21.4 ± 1.8*

21.8 ± 1.7

AOSD activity scores

4.3 ± 2.0

NA

NA

CRP levels (normal <0.3 mg/dL)

2.66 ± 2.44

NA

NA

Ferritin levels (normal <280 μg/L)

1458 ± 4717

NA

NA

SLEDAI

NA

10.0 ± 1.0

NA

C3 (normal 84–160 mg/dL)

NA

86.9 ± 5.9

NA

C4 (normal 12–36 mg/dL)

NA

19.6 ± 2.1

NA

Anti-dsDNA (normal <92.7U/mL)

NA

251.4 ± 36.4

NA

Nephritis

0 (0.0%)

11 (30.6%)**

NA

Smoker (past)

10 (19.2%)

7 (19.4%)

3 (18.8%)

Smoker (present)

6 (11.5%)

5 (13.9%)

2 (12.5%)

Hypertension

4 (7.7%)

9 (25.0%)*§

0 (0.0%)

  1. Data are presented as mean ± SD or number (percentage); NA: not applicable.
  2. CRP: C-reactive protein; SLEDAI: SLE disease activity index; C3: complement 3; C4: complement 4; Anti-ds DNA: anti-double strand DNA antibody; Nephritis is defined by persistent proteinuria (>0.5 g/24 hours) or pathological examination of renal biopsy specimens showing lupus nephritis. *P < 0.05, **p < 0.001, vs. AOSD.
  3. §p < 0.001, vs. Healthy controls.